ALLY GORDON: Open Payments
NPI 1487832663 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 41 payments from 8 companies in 2025. Trend: 2023 $908 · 2024 $1,106 · 2025 $1,299
Food & beverage: $1,264Education: $35
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $372 |
| ABBVIE INC. | 15 | $336 |
| Sumitomo Pharma America, Inc. | 10 | $311 |
| IMMUNITYBIO, INC. | 1 | $135 |
| Valencia Technologies Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: INTERSTIM, BOTOX, GEMTESA, ANKTIVA, eCoin Device Kit, IMFINZI, ERLEADA, ALTAVIVA.
Industry payments across MD — which companies pay providers there.
